[1] |
Zheng J, Yuan Q, Zhou C, et al. Mitochondrial stress response in drug-induced liver injury. Mol Biol Rep, 2021, 48(10):6949-6958.
|
[2] |
Zhao L, Wang Y, Zhang Y. The potential diagnostic and therapeutic applications of exosomes in drug-induced liver injury. Toxicol Lett, 2021, 1, 337:68-77.
|
[3] |
European Association for the Study of the Liver. EASL clinical practice guidelines:Drug -induced liver injury. J Hepatol, 2019, 70(6):1222 -1261.
|
[4] |
Llewellyn HP, Vaidya VS, Wang Z, et al. Evaluating the Sensitivity and Specificity of Promising Circulating Biomarkers to Diagnose Liver Injury in Humans. Toxicol Sci, 2021, 181(1):23-34.
|
[5] |
Miller CG, Kundert JA, Prigge JR, et al. Supplemental Ascorbate Diminishes DNA Damage Yet Depletes Glutathione and Increases Acute Liver Failure in a Mouse Model of Hepatic Antioxidant System Disruption. Antioxidants (Basel), 2021, 10(3):359.
|
[6] |
Korver S, Bowen J, Pearson K, et al. The application of cytokeratin-18 as a biomarker for drug-induced liver injury. Arch Toxicol, 2021, 95(11):3435-3448.
|
[7] |
Church RJ, Schomaker SJ, Eaddy JS, et al. Glutamate dehydrogenase as a biomarker for mitotoxicity; insights from furosemide hepatotoxicity in the mouse. PLoS One, 2020, 15(10):e0240562.
|
[8] |
Schomaker S, Potter D, Warner R, et al. Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments. PLoS One, 2020, 15(5):e0229753.
|
[9] |
Church RJ, Kullak-Ublick GA, Aubrecht J, et al. Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort. Hepatology, 2019, 69(2):760-773.
|
[10] |
Villanueva-Paz M, Morán L, López-Alcántara N, et al. Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice. Antioxidants (Basel), 2021, 10(3):390.
|
[11] |
Kıvanç MR, Türkoglu V. Investigation of the effects of natural compounds isolated from Arum rupicola var. rupicola on glutathione reductase enzyme purified from bovine liver. Biomed Chromatogr, 2019, 33(8):e4560.
|
[12] |
Chowdhury A, Nabila J, Adelusi TI, et al.Current etiological comprehension and therapeutic targets of acetaminophen-induced hepatotoxicity. Pharmacol Res, 2020, 161:105102.
|
[13] |
Ntamo Y, Ziqubu K, Chellan N, et al. Drug-Induced Liver Injury: Clinical Evidence of N-Acetyl Cysteine Protective Effects. Oxid Med Cell Longev, 2021, 2021:3320325.
|
[14] |
Cipriano M, Pinheiro PF, Sequeira CO, et al. Nevirapine biotransformation insights: an integrated in vitro approach unveils the biocompetence and glutathiolomic profile of a human hepatocyte-like cell 3D model. Int J Mol Sci, 2020, 21:3998.
|
[15] |
Xu J, Oda S, Yokoi T. Cell-based assay using glutathione-depleted HepaRG and HepG2 human liver cells for predicting drug-induced liver injury. Toxicol In Vitro, 2018, 48:286-301.
|